Selection and identification of single domain antibody fragments from camel heavy-chain antibodies: FEBS Lett.

Download
  1. Get@NRC: Selection and identification of single domain antibody fragments from camel heavy-chain antibodies: FEBS Lett. (Opens in a new window)
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for:
TypeArticle
Journal titleFEBS Lett.
Volume414
Issue3
Pages521526; # of pages: 6
SubjectAmino Acid Sequence; Animals; Antibodies; antibody; Antibody Affinity; Antibody Specificity; ANTIGEN; Antigens; Bacteriophages; binding; Binding Sites; Binding Sites,Antibody; BINDING-SITE; Camels; CHAIN; CHAINS; Cloning,Molecular; DOMAIN; Epitope Mapping; Gene Library; genetics; IDENTIFICATION; Immunoglobulin Heavy Chains; immunology; Light; metabolism; Molecular Sequence Data; Polymerase Chain Reaction; protein; Proteins; Recombinant Proteins; SELECTION; SITE; SITES
AbstractFunctional heavy-chain gamma-immunoglobulins lacking light chains occur naturally in Camelidae. We now show the feasibility of immunising a dromedary, cloning the repertoire of the variable domains of its heavy-chain antibodies and panning, leading to the successful identification of minimum sized antigen binders. The recombinant binders are expressed well in E. coli, extremely stable, highly soluble, and react specifically and with high affinity to the antigens. This approach can be viewed as a general route to obtain small binders with favourable characteristics and valuable perspectives as modular building blocks to manufacture multispecific or multifunctional chimaeric proteins
Publication date
LanguageEnglish
AffiliationNRC Institute for Biological Sciences; National Research Council Canada
Peer reviewedNo
NRC numberARBABI1997
NPARC number9363882
Export citationExport as RIS
Report a correctionReport a correction
Record identifierb60221b6-7c81-427a-90b8-e7edf5717069
Record created2009-07-10
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)